... cell FEBS Journal 277 (2 010 ) 16 84 16 94 ª 2 010 The Authors Journal compilation ª 2 010 FEBS J Xiong et al 10 11 12 13 14 15 16 17 18 19 20 21 22 proliferation and adhesion-independent growth Cancer ... MDA-MB-2 31 cells were maintained in 10 % fetal bovine serum-supplemented L -15 (Gibco, Grand Island, NY, USA); SK-BR-3 cells were maintained in 10 % fetal bovine serum-supplemented RPMI -16 40 (Hyclone); ... the binding site of miR-22, forming pGL3m–ESR1–3¢UTR–MUT The ERa-expressing vector (pcDNA3 .1 ESR1) was created by cloning the ESR1 coding sequence into the EcoRI and NheI sites of pcDNA3 .1 (Invitrogen)...
... and was assisted in these experiments by JAB and JAAG MM and CR helped in designing appropriate Muc16 primers JC assisted in obtaining and maintaining murine ovarian tumor cells MK assisted in ... and intracellular Muc16 in the four MOVCAR cell lines was determined by flow cytometry using the 618 F antibody The mean fluorescence intensity for the binding of 618 F to the cell surface and intracellular ... line (B) MOVCAR -10 cells were fixed andexpression of intracellular Muc16 was detected by using the 618 F antibody (grey line) Dark line shows isotype control (C) Expression of cell surface and...
... Fostira, 2 013 ) In addition to BRCA1/2, TP53 and PTEN, there are other high-penetrant genes such as STK 11 (serine/threonine kinase 11 ) and CDH1 (cadherin 1) Mutation of STK 11 gene increased the ... signal-regulated kinases 1/ 2 (ERK1/2), c-Jun amino (N)-terminal kinases 1/ 2/3 (JNK1/2/3) and p38 isoforms (α, β, γ and δ) Usually, ERK1/2 is involved in cell proliferation and differentiation, while JNK and ... 38 2 .13 Gene silencing with siRNA 39 2 .14 Breast tumor xenograft mouse model 39 2 .15 Hematoxylin and Eosin (H&E) staining 40 2 .16 TUNEL staining 41 2 .17 Ki67 immunohistochemistry...
... recombinant full-length Cdt1 and geminin (HisT7-geminin and His-geminin, amount of recombinant protein run in each lane in ng is indicated) and immunoblotted with anti- Cdt1 and anti- geminin Ig ... inhibiting its MCM loading function [12 ,15 ,16 ] During the cell cycle, geminin is expressed in S and G2 phases, when licensing should be inhibited and when the Cdt1 protein is undetectable [13 ,16 ] ... and geminin mRNAs are down-regulated in G0 During the cell cycle, Cdt1 and geminin mRNA levels are mostly stable and protein levels are primary controlled by Fig Expression of Cdt1 and geminin proteins...
... HLA-DR CD 71 CD 71 CD 71 CD 71 12.6 2.3 31. 2 16 .3 13 .6 14 .1 2 .1 1.9 + MbCD + MbCD + MbCD + MbCD ± ± ± ± ± ± ± ± 1. 9 1. 5 0.9 1.1 2.2 2.6 0.8 1.1In order to see whether localization of CD25 in DRM depends ... containing 73% (w/v) sucrose and lL of protease inhibitor cocktail (1. 5 mgÆmL )1 aprotinin, 1. 5 mgÆmL )1 leupeptin, 1. 5 mgÆmL )1 pepstatin, 70 mM benzamidin, 14 mM diisopropyl fluorophosphate and ... virus I (HTLV- I) [24] MT -1 is also an adult T cell leukemia cell line associated with HTLV- 1and is deficient in the signaling IL-2Rb and c subunits [25] All cell lines were cultured in RPMI -16 40...
... 1. 15 .1. 1), glutathione peroxidase (GPX, EC 1. 11. 1.9) and catalase (EC 1. 11. 1.6), and low molecular weight antioxidants, such as vitamins and various biological dyes, can reduce ROS in vivo [16 19 ] ... H2O2 and lipid hydroperoxides [10 12 ] In addition, ROS derived from leukocytes induce excessive in ammation, leading to cell and tissue damage [13 ,14 ] In extreme instances, such as endotoxin shock, ... show antioxidant, antinociceptive, neuroprotective and anti- in ammatory properties in different experimental models [30–35] Ebselen inhibits leukocyte in ltration and activation, leading to elimination...
... fluorescence intensity was 19 5 in the off-state and 18 60 in 786 Doxycycline – Relative background transcription (%) 0. 014 0. 014 0.0 011 0.0052 0.045 0.0 017 0.068 0.0077 0.0 31 0. 012 1. 4 1. 6 0.096 0.33 1. 9 ... X -10 0 in mmolÆL )1 Tris-HCl pH 7.4, and radioactivity was determined by liquid scintillation counting Uptake of ergothioneine (10 lmolÆL )1) was determined by LC-ESI-MS ⁄ MS Cells were assayed and ... Biol 21, 414 9– 416 1 Yates JL, Warren N & Sugden B (19 85) Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells Nature 313 , 812 – 815 Lupton S & Levine AJ (19 85)...
... 445:8 51- 857 Niehr et al Journal of Translational Medicine 2 011 , 9:76 http://www.translational-medicine.com/content/9 /1/ 76 10 11 12 13 14 15 16 17 18 19 20 21 Flaherty KT, Puzanov I, Kim KB, Ribas A, McArthur ... combined in constant ratios to each other Among the 11 BRAFV600E mutant cell lines, in cell lines the combination was antagonistic andin cell lines it was synergistic (Figure 1b) In two cell lines ... described [19 ] Primary antibodies included pCRAF (Ser289/296/ 3 01) , CRAF, pMEK1/2 (Ser 217 /2 21) , MEK1/2, pERK1/2 (Thr202/Tyr204, Thr185/Tyr187), ERK1/2, pLKB1 (Ser428), LKB1, pAMPKa (Thr172), AMPKa, pACC...
... Medicine 2 011 , 9 :11 0 http://www.translational-medicine.com/content/9 /1/ 110 cancer targets for therapeutics and multiple Aurora kinase inhibitors are currently being studied in early phase I and ... GSK1070 916 in malignancies such as NHL A number of Aurora kinase inhibitors are already in clinical or preclinical development including GSK1070 916 , VX-680, AZD 115 2, PHA-739358, AT9283 and CYC 116 [24-28] ... Spiess PE, Steinberg JR, Wang Z, Katz RL, et al: Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection J Natl Cancer Inst 2008, 10 0 :14 01- 1 411 11 Staff S,...